Ubs Group Ag SPYRE THERAPEUTICS INC Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025
Number of Shares
462,863
Previous 552,243 16.18%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-89,380 Reduced 16.18%
462,863 $0
Q1 2025

May 13, 2025
BUY
N/A
160,046 Added 40.81%
552,243 $0
Q4 2024

Feb 14, 2025
BUY
N/A
334,359 Added 578.1%
392,197 $0
Q3 2024

Nov 14, 2024
BUY
N/A
13,334 Added 29.96%
57,838 $0
Q2 2024

Aug 13, 2024
BUY
N/A
41,903 Added 1611.03%
44,504 $0
Q1 2024

May 13, 2024
SELL
N/A
-1,125 Reduced 30.19%
2,601 $0
Q4 2023

Feb 09, 2024
BUY
N/A
3,726 New
3,726 $0
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email